RBM5 and p53 expression after rat spinal cord injury: implications for neuronal apoptosis

Jinlong Zhang1, Zhiming Cui1, Guijuan Feng2

  • 1Department of Spine Surgery, The Second Affiliated Hospital of Nantong University, Nantong University, 226001 Nantong, Jiangsu, People's Republic of China.

Insights

RNA-binding motif protein 5 (RBM5) promotes neuronal apoptosis after spinal cord injury (SCI) by regulating the p53 signaling pathway. This study reveals RBM5

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cellular Biology

Background:

  • RNA-binding motif protein 5 (RBM5) is a nuclear protein known to regulate apoptosis and cell cycle arrest via the tumor suppressor p53.
  • The role and expression of RBM5 in the context of spinal cord injury (SCI) remain largely uncharacterized.

Purpose of the Study:

  • To investigate the involvement of RBM5 in central nervous system (CNS) injury and repair following acute SCI.
  • To elucidate the specific function of RBM5 in neuronal apoptosis after SCI.

Main Methods:

  • An acute SCI model was established in adult rats.
  • Expression levels of RBM5 and apoptotic markers (p53, Bax, active caspase-3) were analyzed post-SCI.
  • Immunofluorescence was used to examine RBM5 localization and co-localization with active caspase-3 in neurons.
  • A PC12 neuronal cell line was utilized to create an apoptotic model for RBM5 knockdown experiments.

Main Results:

  • RBM5 expression was significantly upregulated following SCI in rats.
  • SCI induced increased levels of apoptotic proteins including p53, Bax, and active caspase-3.
  • RBM5 showed altered localization and co-localized with active caspase-3 in neurons after traumatic SCI.
  • Knockdown of RBM5 in PC12 cells reduced p53 and active caspase-3 levels, confirming its pro-apoptotic role.

Conclusions:

  • RBM5 plays a significant role in promoting neuronal apoptosis after spinal cord injury.
  • RBM5 modulates the p53 signaling pathway, contributing to neuronal cell death following SCI.
  • These findings highlight RBM5 as a potential therapeutic target for mitigating neuronal loss in SCI.

Related Concept Videos